In patients with NAFLD, BGS were significantly correlated with ALB (r = −0.3709, P < 0.05) and the following hepatic fibrosis markers: type IV collagen 7S (r = 0.3556, P < 0.05), P-3-P (r = 0.4796, P < 0.05), the PLT count (r = −0.4114, P < 0.05), and the FIB-4 index (r = 0.3510, P < 0.05). Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.